MA23166A1 - Procedes d'utilisation d'hesperetine pour le controle du sebum et le traitement de l'acne . - Google Patents

Procedes d'utilisation d'hesperetine pour le controle du sebum et le traitement de l'acne .

Info

Publication number
MA23166A1
MA23166A1 MA23472A MA23472A MA23166A1 MA 23166 A1 MA23166 A1 MA 23166A1 MA 23472 A MA23472 A MA 23472A MA 23472 A MA23472 A MA 23472A MA 23166 A1 MA23166 A1 MA 23166A1
Authority
MA
Morocco
Prior art keywords
hesperetine
acne
treatment
methods
sebum control
Prior art date
Application number
MA23472A
Other languages
English (en)
Inventor
T Akadiri Adeloba
Warren Raphael
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MA23166A1 publication Critical patent/MA23166A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/008—Preparations for oily hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
MA23472A 1993-04-20 1994-04-18 Procedes d'utilisation d'hesperetine pour le controle du sebum et le traitement de l'acne . MA23166A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4992393A 1993-04-20 1993-04-20

Publications (1)

Publication Number Publication Date
MA23166A1 true MA23166A1 (fr) 1994-12-31

Family

ID=21962477

Family Applications (1)

Application Number Title Priority Date Filing Date
MA23472A MA23166A1 (fr) 1993-04-20 1994-04-18 Procedes d'utilisation d'hesperetine pour le controle du sebum et le traitement de l'acne .

Country Status (10)

Country Link
US (1) US5587176A (fr)
EP (1) EP0695181A1 (fr)
JP (1) JPH08509224A (fr)
CN (1) CN1123523A (fr)
AU (1) AU6666594A (fr)
CA (1) CA2159985C (fr)
IL (1) IL109334A0 (fr)
MA (1) MA23166A1 (fr)
WO (1) WO1994023717A1 (fr)
ZA (1) ZA942717B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4444238A1 (de) * 1994-12-13 1996-06-20 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden
NZ299379A (en) 1995-10-27 1997-04-24 Unilever Plc Topical flavanone-containing composition
US6238673B1 (en) 1996-09-20 2001-05-29 The Howard Foundation Method of producing high flavonol content polyphenol compositions
US6569446B1 (en) 1996-09-20 2003-05-27 The Howard Foundation Solubilization of flavonols
TR199900610T2 (xx) * 1996-09-20 1999-06-21 The Howard Foundation Polifenol i�eren terkiplerin �retim y�ntemi.
KR100213895B1 (ko) * 1996-10-14 1999-08-02 박원훈 감귤류 과피 추출물, 이로부터 분리 정제된 헤스페리딘 또는 나린진을 포함하는 심혈관 질환 예방및 치료제 조성물
US5690948A (en) * 1997-01-10 1997-11-25 Elizabeth Arden Co., Division Of Conopco, Inc. Antisebum and antioxidant compositions containing guguliped and alcoholic fraction thereof
US6150403A (en) * 1997-10-14 2000-11-21 The Procter & Gamble Company Topical compositions for regulating the oily/shiny appearance of skin
WO1999021549A1 (fr) * 1997-10-28 1999-05-06 Korea Institute Of Science And Technology Hesperidine et hesperetine en tant qu'inhibiteur d'acyle coa-cholesterol-o-acyltransferase, inhibiteur de l'accumulation du complexe macrophages-lipides sur la paroi arterielle et agent prophylactique ou therapeutique de maladies hepatiques
KR100538866B1 (ko) * 1998-01-12 2005-12-23 유니젠 파아마슈티컬스,인크. 알로에신 유도체의 합성방법
US6113949A (en) * 1998-10-27 2000-09-05 Prolab Nutrition, Inc. Weight control product and method of treating hyperlipidemia and increasing vigor with said product
US6831098B1 (en) * 1999-01-27 2004-12-14 Zielinski Laboratory Hesperetin pro-forms with enhanced bioavailablility
WO2000044757A1 (fr) * 1999-01-27 2000-08-03 Zielinski Laboratory Proformes d'hesperitine ayant une disponibilite biologique accrue
US6262117B1 (en) 1999-02-18 2001-07-17 Allergan Sales, Inc. Method and composition for treating acne
US6426362B1 (en) 1999-10-08 2002-07-30 Galileo Laboratories, Inc. Formulations of tocopherols and methods of making and using them
US6528042B1 (en) 1999-10-08 2003-03-04 Galileo Laboratories, Inc. Compositions of flavonoids for use as cytoprotectants and methods of making and using them
FR2800276B1 (fr) * 1999-10-27 2004-08-20 Palbian Snc Composition et medicament, notamment anti-inflammatoire, constitue de ladite composition
EP1262177B1 (fr) * 2001-05-31 2006-08-23 Pfizer Products Inc. Utilisation médicale des composés thyromimétiques pour traiter la chute des cheveux et compositions
MXPA06006773A (es) * 2003-12-18 2006-09-04 Nestec Sa Composicion para mejorar la salud de la piel, el cabello y el pelo, que contiene flavanonas.
AU2011202873B2 (en) * 2003-12-18 2013-05-23 Société des Produits Nestlé S.A. Composition for improving skin, hair and coat health containing flavanones
GB2423928B (en) * 2004-11-16 2008-04-09 Efflux Technology Inc Methods and compositions for treating pain
US20070087977A1 (en) * 2004-11-16 2007-04-19 Wendye Robbins Methods and compositions for treating pain
DE102006062120A1 (de) * 2006-12-22 2008-06-26 Grünenthal GmbH Pharmazeutische Zusammensetzung zur Aknebehandlung
EP2241313A1 (fr) 2009-03-31 2010-10-20 Nestec S.A. Utilisation de flavonoïdes afin d'augmenter la biodisponibilté de l'hespérétine
CN102266320B (zh) * 2010-07-20 2015-06-17 浙江养生堂天然药物研究所有限公司 橙皮素的新用途
CN104224561A (zh) * 2010-07-20 2014-12-24 浙江养生堂天然药物研究所有限公司 橙皮素的新用途
CN104188819B (zh) * 2014-09-25 2016-08-03 山西医科大学 一种透明质酸分散的橙皮素纳米爽肤水及其制备方法
FR3029780B1 (fr) * 2014-12-12 2018-01-19 L'oreal Composition comprenant de l'hesperetine
FR3029783B1 (fr) * 2014-12-12 2018-01-19 L'oreal Composition aqueuse comprenant de l'hesperetine
JP2019508383A (ja) 2016-01-15 2019-03-28 ウニベルジテート ハンブルグＵｎｉｖｅｒｓｉｔａｅｔ Ｈａｍｂｕｒｇ Ｏ−ラムノシル残基を有するフラボノイド型化合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6211M (fr) * 1967-04-21 1968-07-29
US4693623A (en) * 1984-03-02 1987-09-15 Dab-O-Matic Corp. Pressure-responsive valve for an applicator
US5110801A (en) * 1984-08-13 1992-05-05 Leveen Harry H Treatment of acne
JPS6284021A (ja) * 1985-10-08 1987-04-17 Shiseido Co Ltd テストステロン−５α−レダクタ−ゼ阻害剤
JPS62145016A (ja) * 1985-12-18 1987-06-29 Mitsubishi Chem Ind Ltd 抗菌剤
JPH085788B2 (ja) * 1987-10-08 1996-01-24 花王株式会社 ５α−リダクターゼ阻害剤
ATE87204T1 (de) * 1987-12-10 1993-04-15 Tsumura & Co Anti-retrovirales arzneimittel.
US4891228A (en) * 1988-02-02 1990-01-02 Richardson-Vicks Inc. Medicated cleansing pads
JPH02193919A (ja) * 1989-01-23 1990-07-31 Kao Corp 皮脂線抑制剤
JPH035423A (ja) * 1989-06-01 1991-01-11 Ichimaru Pharcos Co Ltd フラボノイド含有過酸化脂質生成抑制剤
JPH0348617A (ja) * 1989-07-17 1991-03-01 Mitsubishi Kasei Corp 抗アンドロゲン剤
JP2940964B2 (ja) * 1989-12-15 1999-08-25 株式会社資生堂 テストステロン―５α―レダクターゼ阻害剤

Also Published As

Publication number Publication date
US5587176A (en) 1996-12-24
EP0695181A1 (fr) 1996-02-07
ZA942717B (en) 1995-01-16
JPH08509224A (ja) 1996-10-01
WO1994023717A1 (fr) 1994-10-27
AU6666594A (en) 1994-11-08
IL109334A0 (en) 1994-07-31
CA2159985C (fr) 1999-07-13
CA2159985A1 (fr) 1994-10-27
CN1123523A (zh) 1996-05-29

Similar Documents

Publication Publication Date Title
MA23166A1 (fr) Procedes d'utilisation d'hesperetine pour le controle du sebum et le traitement de l'acne .
DE69630328D1 (de) Präziser kontrollierter Niederschlag von Sauerstoff in Silizium
DK0808641T3 (da) Praktisk "aftagelig" åndedrætsmaske
DE69621830T2 (de) Alpha-substituierte arylsulphonamidohydroxamsaüre als tnf-alpha und matrix-metalloproteinase-inhibitoren
NO933878L (no) Ultrasonisk behandlingssystem
DE69312828T2 (de) Zugriffsteuerungsverfahren
ITRM940706A0 (it) "isochinoline"
IL105216A0 (en) Method and kit for the diagnosis of alzheimer's disease
DE69328010T2 (de) Client-Server-System und Steuerverfahren dafür
DE69525011T2 (de) Vierquadrantenskalierung von Punktmatrixdaten
DE69416636T2 (de) Flüssigkeits-Steuersystem
FR2675976B1 (fr) Agencement d'appareil de radiocommunication.
DE69221617D1 (de) Aufbereitung von flüssigkeit
DE69313990T2 (de) Gerät zur Durchführung von Transaktionen
NO964190A (no) Terapeutisk smertestillende middel inneholdende "Nimesulid", samt fremgangsmåte ved fremstilling derav
IT1271567B (it) Procedimento per l'ulteriore trattamento di salcicce
FR2706377B1 (fr) Ensemble de manÓoeuvre d'un accélérateur.
MA23388A1 (fr) Benzimidazole substitue , procedes de fabrication et d'application
NO962503D0 (no) Anvendelse av penoksyfyllin ved behandling av multippel sklerose
FR2758135B1 (fr) Procedes et dispositifs pour la desinfection et le recyclage d'un effluent aqueux
AU6098994A (en) Methods and agents for the diagnosis and treatment of rheumatoid arthritis
FR2562113B1 (fr) Perfectionnements aux procedes et dispositifs d'ensouillage
FR2691359B1 (fr) Nouvelle application therapeutique du malate de 1-citrulline.
FR2697421B1 (fr) Appareil de relaxation et de therapie pour thalassotherapie.
FR2681789B1 (fr) Appareil d'assistance cardio-circulatoire.